Dexcel Pharma Technologies Ltd., 10% Owner at Intec Pharma Ltd. (NTEC), sold 1,641,902 shares at $0.31 ($508K) on 2020-01-31, disclosed to the SEC on 2020-02-04.
Open-market sale of $508k NTEC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.31 | 725,951 | $225K | 44.3% |
| 2 | $0.31 | 725,951 | $225K | 44.3% |
| 3 | $0.32 | 80,000 | $26K | 5.0% |
| 4 | $0.29 | 110,000 | $32K | 6.3% |
| Total | $0.31 avg | 1,641,902 | $508K | 100% |
| Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |
| MYOV | BUY | 2019-06-06 | $40.0M | — | Filing → |